Christopher James Hostler, MD

Assistant Professor of Medicine
Campus mail Box 102359, DUMC, Durham, NC 27710
Email address christopher.hostler@duke.edu

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 2016 - 2017
  • Infectious Diseases, Duke University School of Medicine, 2014 - 2015
  • Internal Medicine, Duke University School of Medicine, 2011 - 2014
  • M.D., Duke University School of Medicine, 2011
  • M.P.H., University of North Carolina - Chapel Hill, 2010

Publications

Warren, David K., Katelin B. Nickel, Christopher J. Hostler, Katherine Foy, Jennifer H. Han, Pam Tolomeo, Ian R. Banks, Victoria J. Fraser, Margaret A. Olsen, and Margaret A. CDC Prevention Epicenter Program. “Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction.” Infection Control and Hospital Epidemiology 42, no. 4 (April 2021): 467–70. https://doi.org/10.1017/ice.2020.462.

PMID
33040748
Full Text

Mack, Christina D., Erin B. Wasserman, Cria G. Perrine, Adam MacNeil, Deverick J. Anderson, Emily Myers, Sabrina Smith, et al. “Implementation and Evolution of Mitigation Measures, Testing, and Contact Tracing in the National Football League, August 9-November 21, 2020.” Mmwr Morb Mortal Wkly Rep 70, no. 4 (January 29, 2021): 130–35. https://doi.org/10.15585/mmwr.mm7004e2.

PMID
33507889
Full Text

Shoff, Christopher J., Mary L. Townsend, L Gayani Tillekeratne, Ryan D. Schulteis, Michael E. Yarrington, Nicholas A. Turner, Christopher W. Woods, and Christopher J. Hostler. “Improved empiric antibiotic prescribing for acute cystitis with use of local urinary antibiogram and clinical decision support system.” Infect Control Hosp Epidemiol 41, no. 11 (November 2020): 1351–53. https://doi.org/10.1017/ice.2020.357.

PMID
32811573
Full Text

Hostler, Christopher J., J Bradford Bertumen, Lawrence P. Park, Susan B. Wilkins, and Christopher W. Woods. “Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.” Am J Infect Control 48, no. 10 (October 2020): 1148–51. https://doi.org/10.1016/j.ajic.2019.12.008.

PMID
31911067
Full Text

McRae-Siebenbrodt, Christy, Hans L. Tillmann, and Christopher J. Hostler. “How to Obtain a Nasopharyngeal Swab Specimen.” N Engl J Med 383, no. 3 (July 16, 2020): e14. https://doi.org/10.1056/NEJMc2015949.

PMID
32469476
Full Text

Warren, David K., Katelin B. Nickel, Jennifer H. Han, Pam Tolomeo, Christopher J. Hostler, Katherine Foy, Ian R. Banks, Victoria J. Fraser, Margaret A. Olsen, and Margaret A. CDC Prevention Epicenter Program. “Postdischarge antibiotic use for prophylaxis following spinal fusion.” Infect Control Hosp Epidemiol 41, no. 7 (July 2020): 789–98. https://doi.org/10.1017/ice.2020.117.

PMID
32366333
Full Text

Bari, S., A. Chan, S. R. Jain, and C. J. Hostler. “Outcomes of programmed cell death protein 1 (PD-1) and programmed death-ligand 1(PD-L1) inhibitor therapy in HIV patients with advanced cancer.” Journal of Oncology 2019 (January 1, 2019). https://doi.org/10.1155/2019/2989048.

Full Text

Bari, S., J. Muzaffar, A. Chan, S. R. Jain, A. M. Haider, M. Adams Curry, and C. J. Hostler. “Corrigendum: Outcomes of programmed cell death protein 1 (pd-1) and programmed death-ligand 1 (pd-l1) inhibitor therapy in HIV patients with advanced cancer (Journal of Oncology (2019) 2019 (2989048) DOI: 10.1155/2019/2989048).” Journal of Oncology 2019 (January 1, 2019). https://doi.org/10.1155/2019/7921582.

Full Text

Hostler, Christopher J., Rebekah W. Moehring, Elizabeth S Dodds Ashley, Melissa Johnson, Angelina Davis, Sarah S. Lewis, Daniel J. Sexton, Deverick J. Anderson, and Deverick J. CDC Prevention Epicenters Program. “Feasibility and Value of Developing a Regional Antibiogram for Community Hospitals.” Infect Control Hosp Epidemiol 39, no. 6 (June 2018): 718–22. https://doi.org/10.1017/ice.2018.71.

PMID
29681253
Full Text

Hostler, Christopher J., and Luke F. Chen. “Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.” Expert Opin Pharmacother 14, no. 11 (August 2013): 1529–36. https://doi.org/10.1517/14656566.2013.802307.

PMID
23683070
Full Text